[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Williams et al., 1989 - Google Patents

Aspirin‐like effects of selected food additives and industrial sensitizing agents

Williams et al., 1989

Document ID
3324063680445618344
Author
Williams W
Pawlowicz A
Davies B
Publication year
Publication venue
Clinical & Experimental Allergy

External Links

Snippet

A number of food additives and industrial chemicals, responsible for inducing symptoms of intolerance in some individuals, have been studied in tests measuring platelet activation by noradrenaline. All the investigated agents inhibited platelet aggregation and this was …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl group being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids

Similar Documents

Publication Publication Date Title
TW542721B (en) Dietary supplements containing natural ingredients
Vlachopoulos et al. Effect of dark chocolate on arterial function in healthy individuals
Williams et al. Aspirin‐like effects of selected food additives and industrial sensitizing agents
Mietus-Snyder et al. Endothelial dysfunction occurs in children with two genetic hyperlipidemias: improvement with antioxidant vitamin therapy
Popp et al. A transferable, beta‐naphthoflavone‐inducible, hyperpolarizing factor is synthesized by native and cultured porcine coronary endothelial cells.
Prasad et al. Glutathione reverses endothelial dysfunction and improves nitric oxide bioavailability
Cronberg et al. Effect on platelet aggregation of oral administration of 10 non‐steroidal analgesics to humans
TURNER et al. Some clinical studies of acute hepatitis occurring in soldiers after inoculation with yellow fever vaccine; with especial consideration of severe attacks
Suneetha et al. Cardamom extract as inhibitor of human platelet aggregation
Demling et al. Endotoxemia causes increased lung tissue lipid peroxidation in unanesthetized sheep
Yamazaki et al. Enhancement of ADP-induced platelet aggregation by exercise test in coronary patients and its prevention by pyridinolcarbamate
Rosoff et al. Reduction of platelet serotonin and the response to pulmonary emboli
Ross-Lee et al. Plasma levels of aspirin following effervescent and enteric coated tablets, and their effect on platelet function
Green et al. A study of the variable response of human platelets to collagen: relation to aspirin-induced inhibition of aggregation
Taylor et al. The effects of varying doses of aspirin on human platelet activation induced by PAF, collagen and arachidonic acid.
Lillemoe et al. Caffeine prevents cholesterol gallstone formation
Asad et al. Specific desensitization in ‘aspirin‐sensitive’urticaria; plasma prostaglandin levels and clinical manifestations
Lovenberg Psycho-and vasoactive compounds in food substances
Haines et al. A fatal poisoning from an amatoxin containing Lepiota
Dann et al. Phenylpyruvic oligophrenia. Report of a case in an infant with quantitative chemical studies of the urine
KAUFMAN Trichiniasis: clinical considerations
Campbell Effect of controlled running on serum cholesterol of young adult males of varying morphological constitutions
Zwierzina et al. A method of testing platelet aggregation in native whole blood
Spector et al. Clinical responses and serum prostaglandin levels in aspirin idiosyncrasy: Effect of aspirin and a new nonsteroidal anti-inflammatory agent
JP7070933B2 (en) Oral composition containing β-escin to reduce acetaldehyde toxicity